Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited

It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2001-2002. During the financial year, The Company’s Sales increased by 58% to Rs. 15,578 million, or US$ 319 million. EBITDA doubled to Rs. 5,314 million, or US$ 109 million and EBITDA margin increased from 26% in 2000-01 to 34% in 2001-02. Profit after tax (PAT) more than trebled to Rs. 4,597 million, or US$ 94 million. And, earnings per share (EPS) grew from Rs. 22.83 in 2000-01 to Rs. 60.41 in 2001-02.

The Board of Directors is pleased to recommend a dividend of Rs. 2.50 per equity share of Rs. 5/- for the financial year 2001-2002. This dividend along with the interim dividend of 100%, which has already been paid, raises the total dividend for the financial year 2001-2002 to 150%.

More Annual Report of Dr. Reddy’s Laboratories Limited: